By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ViiV Healthcare 

Five Moore Drive

Research Triangle Park  North Carolina  27709-3398  U.S.A.
Phone: 877-844-8872 Fax: n/a


Company News
ViiV Healthcare To Progress Collaboration With Janssen To Develop The First Long-Acting, Two Drug Injectable Regimen For Treatment Of HIV-1 Infection 1/7/2016 6:55:21 AM
ViiV Healthcare Awards Additional Round Of Grants To Support Innovative HIV Programs Aimed At Reducing Disparities In The Southern U.S. 11/20/2015 9:44:45 AM
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared 11/3/2015 7:08:09 AM
ViiV Healthcare Announces Positive Headline Results From A Study Of Two Drug Injectable Regimen For HIV Maintenance Therapy 11/3/2015 6:52:02 AM
ViiV Healthcare Awards Innovative Grants For HIV Programs Focused On MSM Youth 11/2/2015 10:56:08 AM
ViiV Healthcare Awards 23 Small Grants to Help Alleviate the Stigma of HIV and AIDS in the MSM and Transgender Community Globally 10/26/2015 10:34:22 AM
ViiV Healthcare Release: New Phase IIIb/IV Data Show Switching To Once-Daily Triumeq Maintains HIV Viral Suppression 9/23/2015 11:27:46 AM
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall 7/9/2015 6:41:40 AM
ViiV Healthcare And Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply Of Dolutegravir In China And Several Developing Countries 7/2/2015 6:26:06 AM
ViiV Healthcare And CHAI Collaboration Delivers Second Milestone With First Filing With The FDA Of Generic Dolutegravir By Aurobindo Pharma (AUROBINDOP.BO) For The Treatment Of HIV 5/26/2015 7:31:55 AM